Research Program
Building India-relevant evidence for earlier pancreatic cancer detection.
Genoll’s research direction focuses on molecular signal development and Indian patient cohort relevance, building population-specific evidence for the earlier-detection window in pancreatic cancer.
Cohort Separation Map
Illustrating distinct molecular groups.
Showing how an illustrative multi-omics workspace can compare candidate signal groups against reference context.
Lead Program Selection
Why pancreatic cancer flagship?
Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the world's most aggressive malignancies, with poor overall survival. Because it progresses silently without early symptoms, many patients are diagnosed at advanced stages when options are limited.
Earlier-stage detection supports curative surgical resection and localized clinical options. Starting here lets Genoll build a careful evidence base for its multi-omics work.
Late-Stage Diagnoses
Most pancreatic cancers are found at advanced stages due to deep anatomical localization and lack of screening, making early molecular indicators a crucial medical need.
Prognostic Potential
Earlier detection supports timely surgical intervention, which is key to improving survival rates and expanding treatment options.
Overcoming Limits
Single biomarkers like CA 19-9 are prone to high false-positives/negatives. Genoll combines multiple molecular layers and clinical factors to build reproducible signal patterns.
Demographic Detail
By building specific regional cohorts, we explore how early pancreatic signals manifest in South Asian patient backgrounds, filling a gap in population-relevant evidence.
Discovery Core
Research focus areas
FOCUS AREA 1
Pancreatic pathway biology
Mapping transcriptomic and pathway-level changes, gene expressions, and protein changes that express oncogenic activity along the pancreatic cancer progression pathway.
FOCUS AREA 2
Pre-analytical ML calibration
Developing machine learning models to identify and correct for pre-analytical variables, sample timing, and preservation noise to isolate clean biological signals.
FOCUS AREA 3
Multi-omics signal integration engine
Refining machine learning models that synthesize genomic, transcriptomic, and proteomic layers to identify high-dimensional cancer patterns and optimize classification.
FOCUS AREA 4
India and South Asian cohort context
Evaluating target candidate signals against regional clinical risk factors, South Asian genetic variations, and oncology workflow models to preserve local specificity.
Collaboration
Join us in advancing early cancer detection.
See how we collaborate with clinical labs, biobanks, discovery partners, and oncology networks to validate early-detection signals.